loadpatents
Patent applications and USPTO patent grants for Tulshian; Deen.The latest application filed is for "inhibitors of irak4 activity".
Patent | Date |
---|---|
Inhibitors of IRAK4 activity Grant 9,598,440 - Seganish , et al. March 21, 2 | 2017-03-21 |
Amidopyrazole inhibitors of interleukin receptor-associated kinases Grant 9,169,260 - McElroy , et al. October 27, 2 | 2015-10-27 |
Inhibitors Of Irak4 Activity App 20150299224 - SEGANISH; W. MICHAEL ;   et al. | 2015-10-22 |
Amidopyrazole Inhibitors Of Interleukin Receptor-associated Kinases App 20140194404 - McElroy; William T. ;   et al. | 2014-07-10 |
Substituted triazolopyridines and analogs thereof Grant 8,685,967 - Ho , et al. April 1, 2 | 2014-04-01 |
Adenosine A.sub.2a receptor antagonists Grant RE44,205 - Neustadt , et al. May 7, 2 | 2013-05-07 |
Polycyclic guanine derivatives and use thereof Grant 8,349,858 - Tulshian , et al. January 8, 2 | 2013-01-08 |
DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b] PURIN-4(5H)-ONE and METHODS OF USE THEREOF App 20120316176 - Tulshian; Deen ;   et al. | 2012-12-13 |
Substituted Triazolopyridines And Analogs Thereof App 20120028975 - Ho; Ginny D. ;   et al. | 2012-02-02 |
mGluR1 antagonists as therapeutic agents Grant 7,989,464 - Matasi , et al. August 2, 2 | 2011-08-02 |
3-monosubstituted tropane derivatives as nociceptin receptor ligands Grant 7,910,603 - Ho , et al. March 22, 2 | 2011-03-22 |
Polycyclic Guanine Derivatives And Use Thereof App 20110065738 - Tulshian; Deen ;   et al. | 2011-03-17 |
Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism Grant 7,638,526 - McKittrick , et al. December 29, 2 | 2009-12-29 |
mGluR1 antagonists as therapeutic agents Grant 7,598,259 - Matasi , et al. October 6, 2 | 2009-10-06 |
mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS App 20090192178 - Matasi; Julius J. ;   et al. | 2009-07-30 |
3-monosubstituted Tropane Derivatives As Nociceptin Receptor Ligands App 20090105248 - Ho; Ginny D. ;   et al. | 2009-04-23 |
mGluR1 Antagonists as Therapeutic Agents App 20090082336 - Matasi; Julius J. ;   et al. | 2009-03-26 |
mGluR1 antagonists as therapeutic agents Grant 7,485,648 - Matasi , et al. February 3, 2 | 2009-02-03 |
High affinity ligands for nociceptin receptor ORL-1 Grant 7,485,650 - Sawutz , et al. February 3, 2 | 2009-02-03 |
3-monosubstituted tropane derivatives as nociceptin receptor ligands Grant 7,479,494 - Ho , et al. January 20, 2 | 2009-01-20 |
Azetidine Derivatives Useful In Treating Pain, Diabetes And Disorders Of Lipid Metabolism App 20080089858 - McKittrick; Brian A. ;   et al. | 2008-04-17 |
Treating Pain, Diabetes, And Disorders Of Lipid Metabolism App 20080070892 - Harris; Joel M. ;   et al. | 2008-03-20 |
3-Monosubstituted tropane derivatives as nociceptin receptor ligands App 20070249604 - Ho; Ginny D. ;   et al. | 2007-10-25 |
High affinity ligands for nociceptin receptor ORL-1 App 20060217414 - Sawutz; David G. ;   et al. | 2006-09-28 |
High affinity ligands for nociceptin receptor ORL-1 Grant 7,094,784 - Tulshian , et al. August 22, 2 | 2006-08-22 |
mGluR1 Antagonists as therapeutic agents App 20060167029 - Matasi; Julius J. ;   et al. | 2006-07-27 |
Adenosine A2a receptor antagonists Grant 7,041,666 - Matasi , et al. May 9, 2 | 2006-05-09 |
mGluR1 antagonists as therapeutic agents App 20060009477 - Matasi; Julius J. ;   et al. | 2006-01-12 |
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 Grant 6,903,123 - Burnett , et al. June 7, 2 | 2005-06-07 |
Adenosine A2a receptor antagonists Grant 6,897,216 - Neustadt , et al. May 24, 2 | 2005-05-24 |
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 App 20040157822 - Burnett, Duane A. ;   et al. | 2004-08-12 |
High affinity ligands for nociceptin receptor ORL-1 App 20040152707 - Tulshian, Deen ;   et al. | 2004-08-05 |
Heteroaryl tropane derivatives as superior ligands for nociceptin receptor ORL-1 Grant 6,727,254 - Tulshian , et al. April 27, 2 | 2004-04-27 |
High affinity ligands for nociceptin receptor ORL-1 App 20040067950 - Tulshian, Deen ;   et al. | 2004-04-08 |
High affinity ligands for nociceptin receptor ORL-1 Grant 6,716,846 - Tulshian , et al. April 6, 2 | 2004-04-06 |
Adenosine A2a receptor antagonists App 20040023997 - Neustadt, Bernard R. ;   et al. | 2004-02-05 |
Adenosine A2a receptor antagonists Grant 6,653,315 - Tulshian , et al. November 25, 2 | 2003-11-25 |
Adenosine A2a receptor antagonists App 20030212080 - Matasi, Julius J. ;   et al. | 2003-11-13 |
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 App 20030195185 - Burnett, Duane A. ;   et al. | 2003-10-16 |
Adenosine A2a receptor antagonists Grant 6,630,475 - Neustadt , et al. October 7, 2 | 2003-10-07 |
Adenosine A2a receptor antagonists App 20030171381 - Tulshian, Deen ;   et al. | 2003-09-11 |
Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 App 20030119847 - Tulshian, Deen ;   et al. | 2003-06-26 |
High affinity ligands for nociceptin receptor ORL-1 App 20030073690 - Tulshian, Deen ;   et al. | 2003-04-17 |
Adenosine A2a receptor antagonists App 20020099061 - Neustadt, Bernard R. ;   et al. | 2002-07-25 |
High affinity ligands for nociceptin receptor ORL-1 App 20010011092 - Tulshian, Deen ;   et al. | 2001-08-02 |
2-benzyl-polycyclic guanine derivatives and process for preparing them Grant 5,939,419 - Tulshian , et al. August 17, 1 | 1999-08-17 |
2'-[[4'-h alo-[1,1'-biphenyl]-4-yl]methyl]-5'-methyl-spiro[cyclopentane-1,7' (8'H)-[3H] imidazo[2,1-b]purin]-4' (5'H)-ones Grant 5,824,683 - McKittrick , et al. October 20, 1 | 1998-10-20 |
Phosphodiesterase inhibitors Grant 5,091,431 - Tulshian , et al. February 25, 1 | 1992-02-25 |
Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion Grant 4,971,972 - Doll , et al. November 20, 1 | 1990-11-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.